Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Profit After Tax (2017 - 2025)

Historic Profit After Tax for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.

  • Puma Biotechnology's Profit After Tax fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 5931.33%. This contributed to the annual value of $30.3 million for FY2024, which is 4033.63% up from last year.
  • As of Q3 2025, Puma Biotechnology's Profit After Tax stood at $8.8 million, which was down 5647.0% from $5.9 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Profit After Tax high stood at $20.3 million for Q3 2024, and its period low was -$44.7 million during Q3 2021.
  • Moreover, its 5-year median value for Profit After Tax was $3.0 million (2025), whereas its average is $2.1 million.
  • Per our database at Business Quant, Puma Biotechnology's Profit After Tax surged by 171000.0% in 2023 and then tumbled by 44368.31% in 2024.
  • Quarter analysis of 5 years shows Puma Biotechnology's Profit After Tax stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then skyrocketed by 318.84% to $12.3 million in 2023, then skyrocketed by 57.54% to $19.3 million in 2024, then crashed by 54.24% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, $5.9 million for Q2 2025, and $3.0 million during Q1 2025.